EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Analysis of Structures of SARS-CoV-2 Papain-like Protease Bound with Ligands Unveils Structural Features for Inhibiting the Enzyme

Ann Varghese, Jie Liu, Bailang Liu, Wenjing Guo, Fan Dong, Tucker A Patterson, Huixiao Hong iD

Molecules · 2025

DOI: 10.3390/molecules30030491 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2025. Verfasst von Ann Varghese und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA. Hauptthemen laut MEDLINE: SARS-CoV-2, Coronavirus Papain-Like Proteases, Protease Inhibitors, Coronavirus 3C Proteases. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: US Food and Drug Administration (FDA).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID-19 pandemic, driven by the novel coronavirus SARS-CoV-2, has drastically reshaped global health and socioeconomic landscapes. The papain-like protease (PLpro) plays a critical role in viral polyprotein cleavage and immune evasion, making it a prime target for therapeutic intervention. Numerous compounds have been identified as inhibitors of SARS-CoV-2 PLpro, with many characterized through crystallographic studies. To date, over 70 three-dimensional (3D) structures of PLpro complexed ligands have been deposited in the Protein Data Bank, offering valuable insight into ligand-binding features that could aid the discovery and development of effective COVID-19 treatments targeting PLpro. In this study, we reviewed and analyzed these 3D structures, focusing on the key residues involved in ligand interactions. Our analysis revealed that most inhibitors bind to PLpro’s substrate recognition sites S3/S4 and SUb2. While these sites are highly attractive and have been extensively explored, other potential binding regions, such as SUb1 and the Zn(II) domain, are less explored and may hold untapped potential for future COVID-19 drug discovery and development. Our structural analysis provides insights into the molecular features of PLpro that could accelerate the development of novel therapeutics targeting this essential viral enzyme.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Coronavirus Papain-Like ProteasesProtease InhibitorsCoronavirus 3C ProteasesLigandsHumansBinding SitesProtein BindingCOVID-19 Drug TreatmentCOVID-19Antiviral AgentsModels, Molecular

Stichwörter der Autor:innen

3D structuresPLproSARS CoV-2binding sitesligandspapain-like protease

Substanzen

LigandsCoronavirus Papain-Like Proteasespapain-like protease, SARS-CoV-2Protease InhibitorsAntiviral AgentsCoronavirus 3C Proteases

Autor:innen und Institutionen

  • National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA.

ORCID-Profile: Huixiao Hong

Förderung

  • US Food and Drug Administration (FDA)

Zitieren

APA

Varghese, A., Liu, J., Liu, B., Guo, W., Dong, F., Patterson, T. A., & Hong, H. (2025). Analysis of Structures of SARS-CoV-2 Papain-like Protease Bound with Ligands Unveils Structural Features for Inhibiting the Enzyme. Molecules. https://doi.org/10.3390/molecules30030491

Vancouver

Varghese A, Liu J, Liu B, Guo W, Dong F, Patterson TA, et al. Analysis of Structures of SARS-CoV-2 Papain-like Protease Bound with Ligands Unveils Structural Features for Inhibiting the Enzyme. Molecules. 2025. doi:10.3390/molecules30030491

BibTeX
@article{Varghese2025,
  author = {Varghese, Ann and Liu, Jie and Liu, Bailang and Guo, Wenjing and Dong, Fan and Patterson, Tucker A and Hong, Huixiao},
  title = {Analysis of Structures of SARS-CoV-2 Papain-like Protease Bound with Ligands Unveils Structural Features for Inhibiting the Enzyme},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30030491}
}
Kostenlos starten →